JPRN-UMIN000035528已完成1 期
Study on the safety of hepatic arterial infusion of cultured autologous bone marrow cells in patients with decompensated liver cirrhosis - Study on the safety of liver regeneration therapy with hepatic arterial infusion of cultured autologous bone marrow cells
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with a current history of malignant neoplasm. (2) Patients with gastroesophageal varices at risk of rupture. (5) Patients with a hemoglobin <8 g/dL, a platelet count <50,000/uL, or a prothrombin time <40%. (6) Patients with renal insufficiency and a serum creatinine greater than or equal to 2 mg/dL. (7) Patients with a performance status of 3 or 4. (8) Patients who refuse to consent to allogeneic blood transfusion. (10) Women who are pregnant. (12) Patients with a current or previous severe allergic reaction to anesthesia. (13) Patients with a current or previous severe allergic reaction to a contrast agent. (14) Patients with a current or previous severe allergic reaction to beef, cow milk. (15) Patients who had an experience with other cell therapy or other clinical study of cell therapy. (17) Any patient deemed unsuitable for study inclusion by their attending physician.
研究者
相似试验
招募中
不适用
Study of the efficacy of hepatic arterial infusion therapy (modified Circadian chronotherapy) for unresectable colorectal cancer liver metastasisJPRN-UMIN000018215Yokohama City University Hospital28
招募中
不适用
The efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced intrahepatic cholangiocarcinomaadvanced intrahepatic cholangiocarcinomaJPRN-UMIN000007303Iwate Medical University50
已完成
1 期
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
已完成
不适用
Clinical trial of hepatic arterial infusion chemotherapy with multidrug resistance-associated protein 3-derived peptide for hepatocellular carcinomaHepatocellular carcinoma (HCC)JPRN-UMIN000005678Department of Gastroenterology, Kanazawa University Hospital12
已完成
不适用
Pilot study of hepatic arterial infusion chemotherapy followed by sorafenib for advanced hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000009094Department of Gastroenterology and Metabolism,Hiroshima University Hospital55